Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.

Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2001 Feb;9(1):14-23.

PMID:
11519628
2.

A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes.

Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE.

Exp Clin Psychopharmacol. 2002 Aug;10(3):228-40.

PMID:
12233983
3.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
4.

A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.

Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML.

J Consult Clin Psychol. 2004 Oct;72(5):839-54.

PMID:
15482042
5.

A randomized controlled trial of the therapeutic workplace for community methadone patients: a partial failure to engage.

Knealing TW, Wong CJ, Diemer KN, Hampton J, Silverman K.

Exp Clin Psychopharmacol. 2006 Aug;14(3):350-60.

PMID:
16893278
6.

A web-based therapeutic workplace for the treatment of drug addiction and chronic unemployment.

Silverman K, Wong CJ, Grabinski MJ, Hampton J, Sylvest CE, Dillon EM, Wentland RD.

Behav Modif. 2005 Mar;29(2):417-63.

PMID:
15657415
7.

Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.

Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Exp Clin Psychopharmacol. 2001 Aug;9(3):317-25.

PMID:
11534542
8.

Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.

Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Psychopharmacology (Berl). 1999 Sep;146(2):128-38.

PMID:
10525747
9.

Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL.

Arch Gen Psychiatry. 1996 May;53(5):409-15.

PMID:
8624184
10.

Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients.

Donlin WD, Knealing TW, Needham M, Wong CJ, Silverman K.

J Appl Behav Anal. 2008 Winter;41(4):499-516.

11.

Effects of reinforcer magnitude on data-entry productivity in chronically unemployed drug abusers participating in a Therapeutic Workplace.

Wong CJ, Sheppard JM, Dallery J, Bedient G, Robles E, Svikis D, Silverman K.

Exp Clin Psychopharmacol. 2003 Feb;11(1):46-55.

PMID:
12622343
12.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
13.

Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.

Katz EC, Chutuape MA, Jones HE, Stitzer ML.

Exp Clin Psychopharmacol. 2002 May;10(2):136-43.

PMID:
12022799
14.

The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.

Jones HE, Haug N, Silverman K, Stitzer M, Svikis D.

Drug Alcohol Depend. 2001 Feb 1;61(3):297-306.

PMID:
11164694
15.

Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.

Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL.

J Consult Clin Psychol. 1998 Oct;66(5):811-24.

PMID:
9803700
16.

Single- versus dual-drug target: effects in a brief abstinence incentive procedure.

Correia CJ, Dallery J, Katz EC, Silverman K, Bigelow G, Stitzer ML.

Exp Clin Psychopharmacol. 2003 Nov;11(4):302-8.

PMID:
14599264
17.

Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.

Preston KL, Umbricht A, Epstein DH.

Arch Gen Psychiatry. 2000 Apr;57(4):395-404.

PMID:
10768702
18.

The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K.

Prev Med. 2014 Nov;68:62-70. doi: 10.1016/j.ypmed.2014.02.021.

19.

Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use.

Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD.

J Consult Clin Psychol. 1997 Jun;65(3):421-8.

PMID:
9170765
20.

Effects of urine testing frequency on outcome in a methadone take-home contingency program.

Chutuape MA, Silverman K, Stitzer ML.

Drug Alcohol Depend. 2001 Mar 1;62(1):69-76.

PMID:
11173169

Supplemental Content

Support Center